CIK 0001478320 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in WA · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 277.0 M | 185.3 M |
| Net income (USD) | -59.5 M | -200.2 M |
| Diluted EPS (USD/shares) | -0.39 | -1.4 |
Forms on file (last 1,000): 4 492, 144 87, 8-K 70, 3 32, 10-Q 22, SC 13G/A 14, SC 13G 12, SCHEDULE 13G/A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ADPT (0.002 USD), /gw/filings/filings?ticker=ADPT&form=8-K, /gw/filings/facts?ticker=ADPT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange